相似文献
1
New developments in the diagnosis and treatment of thyroid cancer.
CA Cancer J Clin. 2013 Nov-Dec;63(6):374-94. doi: 10.3322/caac.21195. Epub 2013 Jun 24.
2
Thyroid cancer: a lethal endocrine neoplasm.
Ann Intern Med. 1991 Jul 15;115(2):133-47. doi: 10.7326/0003-4819-115-2-133.
3
4
Genetic mutations in thyroid carcinoma.
Minerva Endocrinol. 2009 Mar;34(1):11-28.
5
Diagnosis and Management of Hereditary Thyroid Cancer.
Recent Results Cancer Res. 2016;205:29-44. doi: 10.1007/978-3-319-29998-3_3.
6
Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
Chirurgia (Bucur). 2006 Mar-Apr;101(2):121-6.
7
Simultaneous medullary carcinoma and differentiated thyroid cancer. Case report.
Ann Ital Chir. 2010 Sep-Oct;81(5):357-60.
8
Medullary, anaplastic, and metastatic cancers of the thyroid.
Semin Oncol. 2010 Dec;37(6):567-79. doi: 10.1053/j.seminoncol.2010.10.010.
9
Thyroid cancer diagnosis and management.
Clin Lab Med. 1993 Sep;13(3):725-34.
10
Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Clin Cancer Res. 2016 Oct 15;22(20):5012-5021. doi: 10.1158/1078-0432.CCR-16-0484.
引用本文的文献
1
Clinical implications of SLC26A7 in thyroid carcinoma: An observational study from TCGA and GEO.
Medicine (Baltimore). 2025 Aug 8;104(32):e43708. doi: 10.1097/MD.0000000000043708.
2
Enhancer hijacking drives FAM20C expression to promote papillary thyroid cancer progression.
Cancer Gene Ther. 2025 Jun 30. doi: 10.1038/s41417-025-00930-8.
3
The Current Understanding of the Molecular Pathogenesis of Papillary Thyroid Cancer.
Int J Mol Sci. 2025 May 13;26(10):4646. doi: 10.3390/ijms26104646.
4
Integrative analysis of ceRNA networks and immune cell infiltration in thyroid cancer for enhanced diagnostic and prognostic insights.
Sci Rep. 2025 Apr 9;15(1):12190. doi: 10.1038/s41598-025-96287-x.
5
The HOX Gene Family's Role as Prognostic and Diagnostic Biomarkers in Hematological and Solid Tumors.
Cancers (Basel). 2025 Jan 15;17(2):262. doi: 10.3390/cancers17020262.
6
Application of machine learning for mass spectrometry-based multi-omics in thyroid diseases.
Front Mol Biosci. 2024 Dec 17;11:1483326. doi: 10.3389/fmolb.2024.1483326. eCollection 2024.
7
The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis.
Sci Rep. 2024 Dec 30;14(1):31580. doi: 10.1038/s41598-024-75750-1.
8
Estrogen enhances the proliferation, migration, and invasion of papillary thyroid carcinoma via the ERα/KRT19 signaling axis.
J Endocrinol Invest. 2025 Mar;48(3):653-670. doi: 10.1007/s40618-024-02473-5. Epub 2024 Oct 25.
9
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma.
World J Nucl Med. 2024 Jun 14;23(3):185-190. doi: 10.1055/s-0044-1787731. eCollection 2024 Sep.
10
From sequencing to validation: NGS-based exploration of plasma miRNA in papillary thyroid carcinoma.
Front Oncol. 2024 Aug 7;14:1410110. doi: 10.3389/fonc.2024.1410110. eCollection 2024.
本文引用的文献
1
Lymph node ratio predicts recurrence in papillary thyroid cancer.
Oncologist. 2013;18(2):157-62. doi: 10.1634/theoncologist.2012-0240. Epub 2013 Jan 23.
2
Impact of lymph node ratio on survival in papillary thyroid cancer.
Ann Surg Oncol. 2013 Jun;20(6):1906-11. doi: 10.1245/s10434-012-2802-8. Epub 2012 Dec 23.
3
Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
Thyroid. 2013 May;23(5):566-74. doi: 10.1089/thy.2012.0181.
4
Clinic-based ultrasound can predict malignancy in pediatric thyroid nodules.
Thyroid. 2012 Aug;22(8):827-31. doi: 10.1089/thy.2011.0494. Epub 2012 Jul 10.
5
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
N Engl J Med. 2012 Aug 23;367(8):705-15. doi: 10.1056/NEJMoa1203208. Epub 2012 Jun 25.
6
Endocrine surgeon-performed US guided thyroid FNAC is accurate and efficient.
World J Surg. 2012 Aug;36(8):1947-52. doi: 10.1007/s00268-012-1592-2.
7
Are there predictors of malignancy in patients with multinodular goiter?
J Surg Res. 2012 May 15;174(2):207-10. doi: 10.1016/j.jss.2011.11.1035. Epub 2011 Dec 20.
8
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin.
Thyroid. 2012 Mar;22(3):310-7. doi: 10.1089/thy.2011.0235. Epub 2012 Feb 7.
9
Preoperative ultrasonography findings predict the need for repeated surgery in papillary thyroid cancer.
Endocr Pract. 2012 May-Jun;18(3):403-9. doi: 10.4158/EP11221.OR.
10
Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
Thyroid. 2012 Feb;22(2):157-64. doi: 10.1089/thy.2011.0177. Epub 2012 Jan 6.
Zotero 插件